Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Clarify how the wash-sale rule applies to ETFs, including practical timing, replacement restrictions, and compliant planning.
9,454 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
As tariffs and a stronger dollar shape markets, IDV’s 4.7% yield just proved its income stream can endure, even as qu...
A big order from China could reshape Boeing's outlook and affect your investments. This guide breaks down the implica...
With rate headlines dominating markets, experts say three actionable moves beat guessing games: automate saving, dive...
Dogecoin strengthens its footing as ETF inflows stay in positive territory through May, with key resistance near $0.1...
Could short squeeze coming for Plug Power stock be the catalyst investors have been waiting for? This article breaks ...
JEPQ offers a near-9.5% yield by pairing Nasdaq-100 stocks with equity-linked notes. But the unsecured counterparty r...
XRP has shed roughly 44% over the past year, prompting renewed debate about a rebound. Analysts point to regulatory c...
In 2026, the iMGP DBi Managed Futures Strategy ETF (DBMF) is delivering an 11% year-to-date gain against a roughly 5%...
The Vatican issues Magnifica Humanitas, a landmark call for AI regulation and human-centric design. Anthropic partici...
A sharp bond selloff has investors seeking guidance on where invest bonds right. This report outlines a practical app...
ETHA’s Spot Ethereum Promise meets a built-in constraint: the iShares Ethereum Trust cannot pass through staking rewa...